歌礼制药-B(01672.HK)12月12日耗资437.4万港元回购30万股

Core Viewpoint - The company, Gilead Sciences-B (01672.HK), announced a share buyback plan, indicating confidence in its financial position and future prospects [1] Group 1: Buyback Details - The company plans to repurchase 300,000 shares at a total cost of HKD 4.374 million [1] - The buyback price per share is set between HKD 14.38 and HKD 14.80 [1]

ASCLETIS-歌礼制药-B(01672.HK)12月12日耗资437.4万港元回购30万股 - Reportify